Press release
Urothelial Cancer Treatment Market Share, Trends, Size, Research and Forecast 2019-2025
A full report of Global Urothelial Cancer Treatment Market is available at: https://www.omrglobal.com/industry-reports/urothelial-cancer-treatment-market
Immunotherapy, also called biologic therapy. This therapy is intended to boost the natural immune system to fight cancer. Immunotherapy is of two types, local therapy, and systemic therapy. Bacillus Calmette-Guerin (BCG), a standard Immunotherapy drug, used for the treatment of urothelial cancer. Through the catheter, it is directly placed into the bladder. Interferon (Roferon-A, Intron A, Alferon), another type of Immunotherapy it is combined with BCG for the treatment of urothelial cancer. Some of the major drugs used in Immunotherapy are Atezolizumab (Tecentriq), Avelumab (Bavencio), Durvalumab (Imfinzi), Nivolumab (Opdivo), Pembrolizumab (Keytruda), and others.
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/urothelial-cancer-treatment-market
The companies present in the market are focused on developing innovative treatment solutions for urothelial cancer treatment. For instance, in May 2016, the company got FDA approval for its cancer immunotherapy Tecentriq (atezolizumab) for the treatment of a specific type of advanced bladder cancer. Further, in 2017, the FDA granted approval to nivolumab (Opdivo) for the treatment of bladder cancer. This makes nivolumab one of the immune checkpoint inhibitor among 5 inhibitors approved for the treatment of bladder cancer. Such advancement is expected to boost the growth of the global urothelial cancer treatment market in the near future.
Global Urothelial Cancer Treatment Market Segmentation
By Therapy Type
• Chemotherapy
• Immunotherapy
• Others ( Targeted Therapy & Radiation Therapy)
For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/urothelial-cancer-treatment-market
Global Urothelial Cancer Treatment Market– Segment by Region
North America
• United States
• Canada
Europe
• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe
Asia-Pacific
• China
• Japan
• India
• Rest of Asia-Pacific
Rest of the World
• Middle East & Africa
• Latin America
Company Profiles
• Adaptimmune Therapeutics Plc
• Alligator Bioscience AB
• Amgen, Inc.
• AndroScience Corp.
• AstraZeneca PLC
• Bristol-Myers Squibb Co.
• Eisai Co. Ltd.
• Eli Lilly and Co.
• F. Hoffmann-La Roche AG
• GlaxoSmithKline PLC
• Johnson & Johnson Service, Inc.
• Merck & Co, Inc.
• Novartis AG
• Pfizer, Inc.
• Sanofi S.A.
• Sun Pharmaceutical Industries, Ltd.
• Teva Pharmaceutical Industries, Ltd.
• Vault Pharma, Inc.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 7803040404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
For More Information, Visit https://www.omrglobal
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Urothelial Cancer Treatment Market Share, Trends, Size, Research and Forecast 2019-2025 here
News-ID: 2071332 • Views: …
More Releases from Orion Market Research
AI-Enabled Imaging Modalities Market Rising Demand and Growth Forecast Through 2 …
AI-enabled imaging modalities market was valued at approximately USD 1.36 billion, and it is projected to reach around USD 19.78 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 34.67% from 2024 to 2033.
AI-Enabled Imaging Modalities Market Overview
The AI-enabled imaging modalities market is experiencing rapid growth, driven by advancements in artificial intelligence and machine learning technologies. These innovations are enhancing the capabilities of various imaging modalities, including…
Tumor Tracking Systems Market Size Analysis, Competitive Insights, Leading Playe …
Global tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033.
Tumor Tracking Systems Market Overview
The tumor tracking systems market is experiencing steady growth, driven by the increasing incidence of cancer and advancements in imaging and tracking technologies. These systems improve the precision of…
Tumor Tracking Systems Market Size Future Scope, Demands and Projected Industry …
Tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033.
Tumor Tracking Systems Market Overview
The tumor tracking systems market is experiencing steady growth, driven by the increasing prevalence of cancer and advancements in imaging technologies. These systems play a crucial role in enhancing the…
SNP genotyping Market Size Analysis, Competitive Insights, Leading Players and G …
SNP genotyping market was valued at approximately USD 31.66 billion, and it is projected to reach around USD 238.25 billion by 2034, reflecting a compound annual growth rate (CAGR) of about 20.1% from 2024 to 2034.
SNP genotyping Market Overview
The SNP genotyping market is experiencing significant growth, driven by advancements in genotyping technologies, an increase in the prevalence of genetic disorders, and the expansion of pharmacogenomics and precision medicine initiatives. This…
More Releases for Immunotherapy
Immunotherapy Drugs Market
Immunotherapy Drugs Market Size reached US$ 288.02 Billion in 2024 and is expected to reach US$ 872.64 Billion by 2033, growing at a CAGR of 13.2% during the forecast period 2025-2033.
The Immunotherapy Drugs Market report by DataM Intelligence provides comprehensive insights and analysis on key market trends, growth opportunities, and emerging challenges. With a commitment to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead…
Anti TIGIT Antibodies Revolutionizing Immunotherapy
Anti-TIGIT antibodies are at the forefront of a revolution in immunotherapy, representing a new class of immune checkpoint inhibitors that have the potential to transform the treatment landscape for cancer. Immunotherapy, which harnesses the body's immune system to fight cancer, has already made significant strides with the introduction of PD-1, PD-L1, and CTLA-4 inhibitors. However, the discovery and development of anti-TIGIT antibodies add a new dimension to this field, offering…
Allergy Immunotherapy Market Combating the Rising Tide: The Allergy Immunotherap …
Allergy Immunotherapy Market is to reach over USD 4.01 billion by the year 2031 - Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Allergy Immunotherapy Market Size, Share & Trends Analysis Report By Treatment Type (SCIT, SLIT), By Allergy Type (Allergic Rhinitis, Asthma), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), Region, Market Outlook And Industry Analysis…
Allergy Immunotherapy Market - Empowering Resilience, Defying Allergies: Advanci …
Newark, New Castle, USA - new report, titled Allergy Immunotherapy Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Allergy Immunotherapy market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Allergy Immunotherapy market. The report offers an overview of the market, which…
Cancer Immunotherapy Market Cancer Immunotherapy Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Immunotherapy: Mending Cancer Regimens
1.1 Preface to Cancer Immunotherapy
1.2 Evolution of Cancer Immunotherapy
2. Categorization of Cancer Immunotherapy
2.1 Specific Cancer Immunotherapy
2.1.1 Cancer Vaccines
2.1.2 Monoclonal Antibodies
2.2 Non-Specific Cancer Immunotherapy
2.2.1 Adoptive Cell Transfer Immunotherapy
2.2.2 Immune Checkpoint Inhibitors
3. Fundamentals…
Global Cancer Immunotherapy Market & Cancer Immunotherapy Clinical Trials Outloo …
Pharmaceutical companies are actively engaged in research and development of cancer immunotherapies because of large unmet medical necessities. Investigators are trying to come forth with innovative cancer immunotherapeutic products having high safety and efficacy profiles which are not offered by conventional therapeutics.
Higher investments in research and development segment could significantly increase the drug discovery rates which will alleviate the medical condition of cancer patients. Simultaneously, technological advancements are being…
